Eloy Rodríguez Rodríguez
Head of the Neurology Department at the Marqués de Valdecilla-IDIVAL University Hospital and Associate Professor of Medicine in the Department of Medicine and Psychiatry at the University of Cantabria
It seems to me an interesting article, of high scientific level and very well done, which opens the way to a new therapeutic target in Alzheimer's disease. Its main limitation is that it is still a study carried out in mice (although there is a part in which they use post mortem tissue from Alzheimer's patients, the 'therapeutic' part is done in transgenic mice).
The fact that it works in transgenic mice, used as Alzheimer's models, is far from being equivalent to a potential efficacy in humans, but it is an avenue that will be worth exploring further in successive studies.